PET/CT is a useful tool to map out the possible sites where the cancer first originated. PET/CT is a form of hybrid imaging that combines computed tomography (CT), an anatomical imaging ...

The FDA has approved the use of Gozellix, a PSMA-PET imaging agent, to help detect prostate cancer using gallium-68 ...

PSMA PET/CT trial will scan up to 1000 men in the UKA new kind of scan that could be key to improving the treatment of high-risk prostate cancer is ...

IBC is a rare, aggressive breast cancer with higher rates in younger women and those of African descent, requiring a ...

Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by ...

Solskin/Getty CT scans ‘routinely’ deliver up to three times the radiation they should, which can lead to 36,000 cases of cancer a year. “In the ninety million CT scans performed annually in ...

CT scans use ionizing radiation, which can damage DNA. While most of the damage is repaired by cells, some errors can cause DNA mutations, potentially leading to cancer down the road. The lifetime ...

Primo Partners with ABX to Bring PB01 Closer to Taiwan’s Prostate Cancer Market. TAIPEI, Taiwan, March 19, 2025 (GLOBE ...

SESAUA annual meeting featured a prostate cancer session and a presentation by Dr. Abhi Moolupuri discussing a PET/CT supplemented approach to omission of pelvic lymph node dissection. The National ...

Telix’s Illuccix prostate cancer PSMA-PET imaging agent approved in the Netherlands: Melbourne, Australia Wednesday, March 19, 2025, 12:00 Hrs [IST] Telix, a biopharmaceutical c ...